Regeneron Pharmaceuticals (REGN)

Net Income

$4.82B

TTM · Period ending: · USD

REGN logo

REGN Net Income

Latest reported$4.82B
REGN TTM Net Income (-$3.30M → $4.82B)
High-resolution chart · PNG

REGN net income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Net Income — Trailing twelve months (TTM) (USD)
Period endingNet Income (USD)
4,817,400,000
4,328,700,000
4,423,400,000
4,504,900,000
4,578,000,000
4,458,600,000
4,499,300,000
4,412,600,000
4,654,500,000
4,321,700,000
3,857,800,000
3,953,600,000
3,991,100,000
4,299,000,000
4,182,700,000
4,338,400,000
5,370,300,000
5,686,800,000
7,933,600,000
8,075,300,000
6,995,500,000
6,205,400,000
4,003,800,000
3,513,200,000
3,156,000,000
2,983,500,000
2,279,300,000
2,115,800,000
2,144,200,000
2,069,255,000
2,427,567,000
2,444,447,000
1,797,566,000
1,591,228,000
1,427,560,000
1,198,511,000
1,278,107,000
1,154,594,000
963,068,000
879,873,000
781,752,000
727,346,000
725,771,000
636,056,000
591,238,000
460,560,000
358,652,000
348,074,000
334,704,000
396,290,000
390,931,000
424,362,000
797,963,000
848,125,000
837,492,000
750,269,000
226,419,000
-27,414,000
-166,662,000
-221,760,000
-182,914,000
-154,424,000
-117,393,000
-104,468,000
-126,360,000
-93,500,000
-82,964,000
-69,923,000
-64,952,000
-85,052,000
-88,573,000
-82,710,000
-64,263,000
-78,986,000
-87,301,000
-105,600,000
-123,500,000
-115,072,000
-111,874,000
-102,337,000
-101,038,000
-108,280,000
-111,703,000
-95,446,000
-62,982,000
-39,406,000
-26,956,000
41,699,000
19,530,000
3,206,000
-10,981,000
-105,623,000
-121,939,000
-127,355,000
-129,042,000
-124,377,000
-117,062,000
-104,177,000
-88,588,000
-76,180,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.